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ABSTRACT
Several human diseases are thought to evolve due to a combination of host genetic mutations and
environmental factors that include alterations in intestinal microbiota composition termed
dysbiosis. Although in some cases, host genetics may shape the gut microbiota and enable it to
provoke disease, experimentally disentangling cause and consequence in such host-microbe
interactions requires strict control over non-genetic confounding factors. Mouse genetic studies
previously proposed Nlrp6/ASC inﬂammasomes as innate immunity regulators of the intestinal
ecosystem. In contrast, using littermate-controlled experimental setups, we recently showed that
Nlrp6/ASC inﬂammasomes do not alter the gut microbiota composition. Our analyses indicated that
maternal inheritance and long-term separate housing are non-genetic confounders that preclude
the use of non-littermate mice when analyzing host genetic effects on intestinal ecology. Here, we
summarize and discuss our gut microbiota analyses in inﬂammasome-deﬁcient mice for illustrating
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Need for controlled experimental design when
evaluating cause and consequence in microbiota
impacts on host health
The symbiotic relationship between the host and its
intestinal commensal microbes is of crucial importance
for immune homeostasis and overall health of the
host.1,2 Sustained shifts in gut microbiota composition
are termed dysbiosis, which are often characterized by
a lower phylogenetic diversity and an over- and/or
under-representation of particular microbial taxa. In
humans, dysbiosis is observed in multiple immune and
metabolic diseases, including inﬂammatory bowel dis-
ease (IBD) and obesity.3-5 The proposed causes for
such diseases include host genetic factors in combina-
tion with external cues, such as environmental expo-
sures and diet.6 These environmental factors could be a
cause of dysbiosis, which then takes advantage of the
host genetic susceptibility to provoke disease. Alterna-
tively, the association of host genetic as well as
microbiota composition changes with disease develop-
ment suggests that in some cases there could be a lin-
ear chain of events, in which host genetic factors ﬁrst
alter the gut microbiota composition, which in turn
causes or contributes to disease pathogenesis. In addi-
tion, rather than being a cause, dysbiosis could be a
consequence of on-going inﬂammation and immune
responses in patients, especially when concerning intes-
tinal disorders such as IBD. In humans with established
disease, disentangling the host versus microbiota cause
and consequence in disease development is challenging.
Therefore, mouse genetic studies in tightly controlled
environmental conditions provide an elegant approach
to investigate how host-microbiota interactions impact
on intestinal ecology and disease susceptibility.7
Inﬂammasomes are oligomeric complexes in which
particular cytosolic Pattern Recognition Receptors
(PRRs) sense pathogen- or danger-associated cellular
stress leading to caspase-1-dependent maturation of
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the cytokines interleukin (IL)-1b and IL-18.8 Human
and mouse genetic observations suggested inﬂamma-
some deregulation as a potential host factor capable of
provoking dysbiosis-driven intestinal disease. Indeed,
polymorphisms in the gene encoding one of the
inﬂammasome-activating PRRs, NLR nucleotide-
binding domain, leucine-rich and Pyrin containing 3
(Nlrp3), are associated with an increased risk for IBD
development in humans.9-11 Later, studies using
genetic mouse models proposed inﬂammasomes as
major regulators of the intestinal microbiota.12,13
Indeed, deletion of apoptosis-associated speck-like
protein containing a CARD (ASC, encoded by
Pycard), an adaptor protein needed for activating the
Nlrp3 and also other inﬂammasomes, resulted in
intestinal dysbiosis when compared to non-littermate
separately housed C57BL/6 mice.12 Identical observa-
tions in Nlrp6 knockout (KO) mice suggested that the
Nlrp6/ASC inﬂammasome was a key regulator of the
gut microbiota.12 Moreover, a later study showed that
also mice lacking Nlrp3 displayed a similar shift in the
gut microbiota composition when compared with
non-littermate separately housed wild-type (WT)
mice.13 Importantly, the dysbiotic gut microbiota
observed in Nlrp6- or ASC-deﬁcient mice enhanced
colitis development in WT mice. Indeed, WT mice co-
housed with these inﬂammasome-deﬁcient mice
developed more severe Dextran Sodium Sulphate
(DSS)-induced colitis than single housed wild-types,
an effect attributed to horizontal transfer of colito-
genic microbiota derived from the Nlrp6- or ASC-
deﬁcient mice.12 Likewise, horizontal microbiota
transfer from inﬂammasome-deﬁcient mice was pro-
posed to underlie more severe hepatic steatosis and
obesity in co-housed WT mice.13 Together, these stud-
ies suggested the possibility of host genetic inﬂamma-
some defects acting as initial culprits creating a
microbiota composition that is subsequently able to
drive inﬂammatory and metabolic diseases.
Using littermate-controlled experimental setups
with mice deﬁcient in Nlrp6 or ASC, we recently
showed that Nlrp6 and ASC inﬂammasomes do
not perform such a primary causative role in
eliciting dysbiosis and its associated diseases.14
Detailed analyses of the fecal microbiota in these
set-ups, as summarized below, highlighted the
need for carefully designed experiments minimiz-
ing non-genetic confounders such as maternal
inheritance and long-term separate housing when
evaluating the impact of host immunity on intesti-
nal ecosystems.
Littermate-controlled experiments reveal that
mother and cage covariates trump host
inﬂammasomes in shaping the commensal gut
microbiota composition
In our study, we ﬁrst tested the previously employed
experimental set-up analyzing mice originating from
distinct homozygous WT or Nlrp6-deﬁcient breeding
pairs. The fecal microbiota composition of these sepa-
rately housed Nlrp6¡/¡ and non-littermate C57BL/6J
mice in our animal facility did not recapitulate the
reported differences in Prevotellaceae levels, but did
reveal several other differentially represented bacterial
taxa, such as Porphyromonodaceae and Bacteroida-
ceae.14 However, despite these and other individual
taxa differences, the microbiota populations did not
cluster according to the Nlrp6¡/¡ and C57BL/6J geno-
types. Accordingly, distance-based redundancy analy-
ses indicated that between host genetics, mother and
cage covariates, only the latter two signiﬁcantly con-
tributed to the overall observed gut microbiota varia-
tion. Together, these data indicated that the fecal
microbiota variation observed throughout non-litter-
mate Nlrp6¡/¡ and C57BL/6J mice in our animal fa-
cility had been driven by maternal inheritance and
long-term housing separation rather than by host
genetics.14
In order to minimize the impact of these non-genetic
mother and cage drivers of microbiota variation, we
next applied a setup in which littermates from Nlrp6C/
¡ intercrosses were separated according to their geno-
type upon weaning (Fig 1A, left panel). In this
approach, the uniform Nlrp6C/¡ genotype of the moth-
ers allowed for control over the maternal inheritance of
the microbiota, while the limited time spent in separate
cages minimized the non-genetic housing confounder
that was observed in the non-littermate set-up. How-
ever, although reducing the impact of these non-genetic
confounders was expected to more easily detect true
host genetic effects on the gut microbiota, we could not
observe any inﬂuence of Nlrp6 deletion on the fecal
microbiota composition in this littermate-controlled
set-up. Indeed, no alterations in bacterial diversity or in
the microbial community were observed in Nlrp6¡/¡
mice compared to their Nlrp6C/C littermates even after
physical separation up to 1 year of age.14 Even though
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these observations using littermate controls indicated
that Nlrp6 does not impact on the gut microbiota, we
took our analyses a step further by generating mice in
which Nlrp6 deletion could exert its presumed micro-
biota-shifting activity also during the pre-weaning time
that is important for microbiota colonization of the
intestine. For this purpose, the microbiota composition
of F2 homozygous offspring from separately housed
Nlrp6¡/¡ and Nlrp6C/C littermates was analyzed, since
these F2 mice were separated also during the pre-wean-
ing time (Fig 1A, right panel). Strikingly, F2 Nlrp6¡/¡
and F2 Nlrp6C/C mice harbored no differences in their
fecal microbiota communities, indicating that Nlrp6
deﬁciency did not alter the intestinal microbial compo-
sition even when given a lifetime of potential impact.14
Finally, in a parallel series of experiments performed
in an independent animal facility, we used separately
housed littermates obtained from ASCC/¡ intercrosses
to evaluate whether overall inﬂammasome deﬁciency
affected the gut microbiota composition. In this breed-
ing scheme, the ASCC/¡ parents derived from a germ-
free (GF) ASC¡/¡ male and a Speciﬁc Pathogen Free
(SPF) WT C57BL/6J female (Fig 1B), which allowed
analysis of the downstream impact of ASC on a gut
microbiota community that originated solely from one
C57BL/6J mouse. Like in our previous Nlrp6 experi-
ments, ASC¡/¡ and ASCC/¡ littermates separated as
long as 15 weeks after weaning did not display any
genotype-speciﬁc alterations in the fecal bacterial diver-
sity or community structure.14 These analyses showed
that when carefully controlling for maternal inheritance
and housing effects through littermate-controlled set-
ups, Nlrp6 and ASC inﬂammasomes did not affect the
commensal gut microbiota composition.
NLRP6/ASC inﬂammasomes do not shape the
commensal gut microbiota
Our above described results obtained with litter-
mate-controlled experiments contrast to the previ-
ously suggested roles of Nlrp6 and ASC in shaping
the intestinal microbiota composition.12,13,15-17
However, each of these earlier reports was based
on fecal microbiota comparisons between non-
Figure 1. Littermate-controlled, F2 and ex-GF experimental approaches to evaluate host genetic impacts on the gut microbiota. (A)
Breeding scheme used for generating Nlrp6¡/¡ and Nlrp6C/C littermates from non-littermate Nlrp6¡/¡ and WT mice with a suspected
Nlrp6-imposed dysbiosis, with generation of F2 mice for evaluating potential host genetic effects during pre-weaning time. Neither the
Nlrp6¡/¡ and Nlrp6C/C littermates, nor the F2 Nlrp6¡/¡ and Nlrp6C/C mice reproduced the dysbiosis observed in non-littermate Nlrp6¡/
¡ and WT mice. (B) Breeding scheme used to generate ex-GF ASC¡/¡ and ASCC/C littermates from a GF ASC¡/¡ male and an SPF WT
female, in which the latter was the sole gut microbiota donor. Ex-GF ASC¡/¡ and ASCC/C littermates were allowed to colonize their
intestines naturally after birth, and did not show differential gut microbiota compositions.
GUT MICROBES 3
littermate or externally sourced WT and KO mice
that were separately housed for multiple genera-
tions. Several studies demonstrated animal facility-
dependent microbiota differences in otherwise
genetically identical mice,7,18-20 indicating that the
gut microbiota composition can be inﬂuenced by
multiple non-genetic factors. The latter could
include also stochastic events that initiate random
alterations in a given microbiota community, a
novel concept that was recently coined the ‘Anna
Karenina principle’.21 The variety of distinct micro-
bial proﬁles arising due to stochastic triggers can
later mistakenly be interpreted as ‘dysbiosis’ when
transmitted further by maternal inheritance and
preserved due to prolonged colony isolation, a phe-
nomenon known as the legacy effect.22 In fact, we
also encountered a legacy effect in our animal facil-
ity, as none of the littermate-controlled or F2
Nlrp6 analyses reproduced the bacterial taxa differ-
ences that we had initially observed in the non-lit-
termate Nlrp6¡/¡ versus C57BL/6J mice.14 As we
identiﬁed mother and cage covariates as signiﬁcant
contributors to the gut microbiota variation in the
latter set-up, microbial differences observed in
these non-littermate mice likely represented legacy
effects.
In contrast to our results, a recent study using litter-
mate controls still found that the Nlrp6 inﬂammasome
affected the gut microbiota.23 This study investigated
the effect of Nlrp6 deﬁciency on a colitogenic IL-10-
deﬁcient background and observed altered gut micro-
biota composition in Il10¡/¡/Nlrp6¡/¡ versus Il10¡/
¡/Nlrp6C/C littermates.23 However, the authors also
detected differential intestinal inﬂammation between
these Il10¡/¡/Nlrp6¡/¡ and Il10¡/¡/Nlrp6C/C litter-
mates that could underlie the observed effects on intes-
tinal ecology, as intestinal inﬂammation is known to
inﬂuence the composition of the gut microbiota.24
Therefore, Seregin et al. performed re-colonization
experiments in adult GF WT and Nlrp6¡/¡ mice to
assess the role of Nlrp6 on the gut microbiota composi-
tion in the absence of intestinal inﬂammation. Strik-
ingly, fecal microbiota analyses of these ex-GF mice
showed an impact of Nlrp6 on intestinal ecology within
two weeks.23 These observations were similar to a pre-
vious study using an adult ex-GF approach, showing
that the gut microbiota communities of ex-GF WT and
Nlrp6¡/¡ mice diverged at three weeks after re-coloni-
sation.15 However, while this latter ex-GF study did not
specify whether Prevotellaceae alterations previously
observed in non-littermate WT and Nlrp6¡/¡ mice
were reproduced,15 Seregin et al. did not observe those
reported effects on Prevotellaceae and rather found an
increase in Akkermansia muciniphila in ex-GF Nlrp6¡/
¡ mice.23 These discordant observations in ex-GF mice
illustrate that the nature of the donor SPF microbiota
could determine potential host genetic effects on the
gut microbiota in these experiments. Likewise, factors
such as diet and the nature of the resident SPF micro-
biota composition may inﬂuence the impact of a host
gene on the gut microbiota when investigated in differ-
ent animal facilities. However, while the effects of a
host gene on the microbiota may ﬂuctuate across differ-
ent facilities, littermate-controlled experiments within a
given animal facility are ﬁrst needed to exclude non-
genetic confounders and as such to reveal whether this
gene really impacts on the gut microbiota.
Nevertheless, the question arises whether re-colo-
nizing non-littermate adult GF mice as in the Nlrp6
studies mentioned above,15,23 is an alternative valid
approach for investigating host genetic impacts on the
gut microbiota. In our ASC¡/¡ study, we designed an
ex-GF approach that resulted in analyzing WT and
KO littermates that had all colonized their gastrointes-
tinal tract in a natural manner after birth (Fig 1B).14 In
contrast, the ex-GF studies showing Nlrp6 effects on
the gut microbiota used adult mice that were re-colo-
nized by housing in SPF conditions.15,23 Whereas nat-
ural colonization after birth is a gradual process in
which niches are occupied by sequential bacterial col-
onizers, whole microbiota re-colonization in adult
mice is likely to be inﬂuenced by colonization resis-
tance. In addition, as re-colonizing adult GF mice is
accompanied by changes in intestinal physiology and
maturation of the host immune system, also these
host processes could differentially affect the coloniza-
tion success of various gut microbes. For instance, it is
known that the mucus layer of GF mice is more per-
meable for bacterial penetration than that of SPF
mice, a feature that is reverted upon intestinal micro-
bial colonisation.25 In this respect, it is interesting to
note that the Akkermansia muciniphila found to be
enriched in adult ex-GF Nlrp6¡/¡mice are mucus-res-
ident bacteria. Given the reported role for the Nlrp6
inﬂammasome in secreting mucus from sentinel gob-
let cells,26 it is plausible that re-colonizing adult
NLRP6-deﬁcient mice could be associated with differ-
ential repair of the ex-GF mucus layer, which could
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provoke Akkermansia colonization differences when
compared with ex-GF WT mice. Therefore, it would
be interesting to evaluate whether Nlrp6C/C and
Nlrp6¡/¡ littermates derived from the ex-GF mice that
were re-colonized as adults would yield similar Akker-
mansia abundance differences when compared with
direct colonization of adult GF mice. Similar to our
ex-GF approach with ASC¡/¡ mice, such a combined
littermate-based ex-GF approach would allow intesti-
nal development and gut microbiota colonization to
happen in a physiological manner after birth, and
therefore is less likely to be inﬂuenced by experimental
confounders.
Interestingly, our results showing the inability of
inﬂammasomes to shape the commensal gut micro-
biota were recently conﬁrmed by a study using an alter-
native approach to normalize the initial gut microbiota
community. While not using littermates, B»a_zejewski
et al. performed embryo transfers of WT C57BL/6N
and isogenic caspase-1¡/¡ mice to foster mothers har-
boring identical SPF intestinal microbial populations.27
This approach yielded WT and caspase-1¡/¡ mice that
colonized their gastrointestinal tract in a physiological
manner after birth and that acquired normalized SPF
gut microbiota compositions in these genotypes. In an
impressive effort, the authors performed these embryo
transfer experiments in two distinct SPF environments.
The normalized fecal microbiota compositions of the
WT and caspase-1¡/¡ mice did not diverge over time
in either of the SPF animal facilities. Thus, in accor-
dance with our data obtained with ASC-deﬁcient mice,
Caspase-1 deletion in this study showed that overall
inﬂammasome signaling does not impact on the com-
mensal gut microbiota composition.
Inﬂammasomes do not protect from DSS colitis
when normalizing the gut microbiota
composition
Adding to the hypothesis that inﬂammasomes could
be primary regulators of dysbiosis-associated diseases,
Elinav et al. had shown that Nlrp6 deletion conferred
increased susceptibility to DSS colitis secondary to
intestinal microbial changes provoked by Nlrp6 deﬁ-
ciency.12 However, given our ﬁnding that Nlrp6 does
not inﬂuence the gut microbiota composition, the
host genetic effect of Nlrp6 on DSS colitis needed re-
evaluation. Using the F2 Nlrp6¡/¡ and F2 Nlrp6C/C
mice that showed no differences in gut microbiota
composition, we could not observe any difference in
DSS-induced colitis development between these geno-
types.14 As such, our study showed that Nlrp6 neither
affects intestinal microbiota composition nor predis-
poses mice to higher susceptibility to DSS-induced
colitis. Therefore, whilst it is clear that microbial dys-
biosis in some cases can provoke increased colitis,
inﬂammasome deﬁciency does not drive a microbial
dysbiosis capable of doing this. In addition, our DSS
colitis results emphasize the importance of normaliz-
ing the gut microbiota between genotypes in order to
reveal the physiological effect of a given host gene in
DSS colitis.14,28
In this respect, also B»a_zejewski et al. investigated
the inﬂuence of inﬂammasomes on DSS colitis suscep-
tibility after normalizing the intestinal microbiota
composition by embryo transfer. These DSS colitis
experiments, performed in two distinct SPF facilities,
showed that caspase-1 deletion in mice reduced DSS-
induced colitis severity when compared with WT
mice harboring an identical SPF gut microbiota.27
This reduced DSS severity phenotype of caspase-1¡/¡
mice was accompanied with diminished intestinal lev-
els of the inﬂammasome-activated cytokine IL-18.
Indeed, littermate-controlled DSS experiments using
epithelial IL-18-deﬁcient mice (IL-18IEC-KO) had pre-
viously shown a detrimental role for IL-18 production
during DSS colitis development.29 As Nlrp6 deﬁciency
in our gut microbiota normalized DSS experiments
did not exhibit protective effects, other caspase-1
inﬂammasomes presumably can produce sufﬁcient
amounts of mature IL-18 in the absence of Nlrp6. As
it is plausible that the activation of these Nlrp6-inde-
pendent inﬂammasomes depends on the nature and
the activity of the intestinal microbiota, it will be inter-
esting to identify the ligands and the inﬂammasomes
responsible for this IL-18 production in future studies.
Nevertheless, the above DSS studies using gut micro-
biota normalized Nlrp6¡/¡, caspase-1¡/¡ or IL-18IEC-
KO mice (by embryo transfer or by littermate-controlled
experiments) are all in contrast with multiple prior
studies suggesting that mice lacking inﬂammasomes or
IL-18 develop more severe DSS colitis when compared
to non-littermate controls.12,30-32 Thus, these DSS colitis
studies highlight the importance of eliminating non-
genetic impacts on the gut microbiota - such as by
using littermate controls – when studying host genetic




Our recent report studying the impact of Nlrp6/ASC
inﬂammasomes on intestinal ecology clearly showed
the utmost importance to control for non-genetic
mother and cage covariate-driven observations. We
showed that littermate-controlled experimental
design minimizes these confounders and we thereby
showed that Nlrp6/ASC inﬂammasomes – in con-
trast to prior belief stemming from non-littermate
controlled studies – do not shape the commensal gut
microbiota composition.14
Inﬂammasomes were not the ﬁrst innate immu-
nity examples that created confusion with respect to
regulating the intestinal microbiota. Indeed, although
Toll-like receptor (TLR) as well as Nod2 signaling
had been implicated in modelling the intestinal eco-
system,33,34 subsequent studies using littermate com-
parisons showed that these pathways did not exert
the previously described effects on the gut microbiota
composition.20,35 Hence, these studies conﬁrmed
using littermates as the appropriate experimental
setup when investigating host genetic effects in intes-
tinal microbiota regulation. Importantly however,
while none of the above TLR, Nod2 and inﬂamma-
some signaling studies revealed impacts of host
genetics on the gut microbiota using a littermate
approach, it should be noted that physical littermate
separation upon weaning is capable of detecting such
effects. Indeed, studies investigating intestinal epithe-
lial-speciﬁc TLR5 deﬁciency or full-body ablation of
Card9 or IL-33 showed that weaning these genetic
mouse models and their WT littermates in separate
cages resulted in differential gut microbiota commu-
nities after 4–6 weeks of separation.36-38 Together,
these several mouse genetic studies show that analyz-
ing separately housed littermates is a well-controlled
and valid approach for dissecting host genetic effects
on intestinal ecosystems.
Overall, there is clear need for better understand-
ing of the interplay between microbiota and the dif-
ferent players of host innate immune system. We
hope that our recent study illustrated the need for
standardized littermate-controlled experimental
design in this research ﬁeld, as we are convinced
that this approach will minimize experimental dis-
crepancies and will help to identify the causes and
consequences in host-microbiota metagenomic
observations.
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